Loading...
Market
What percentage of eligible patients will receive EnteroMix by end of 2025?
2
Resolution / Starting Odds
Less than 25% • 25%
25% to 50% • 25%
51% to 75% • 25%
More than 75% • 25%
Reports from Russian Ministry of Health or credible health statistics agencies
Story
Russia to Launch Free mRNA Cancer Vaccine in 2025 with 75-80% Tumor Reduction
Dec 17, 2024, 10:01 PM
Russia has announced the development of a cancer vaccine that will be distributed free of charge to cancer patients starting in early 2025. The vaccine, developed by the Ministry of Health in collaboration with the Engelhardt Institute of Molecular Biology and the Gamaleya National Research Center, is reportedly a personalized mRNA-based treatment designed to slow tumor progression and reduce tumor size by up to 75-80%. According to Andrey Kaprin, Chief Oncologist of the Ministry of Health, the vaccine will be offered to patients who have exhausted other treatment options. The clinical trials for the vaccine, named 'EnteroMix,' are set to begin soon, with candidates being selected from patients aged 18 to 75 who have histologically confirmed tumors. The vaccine is not intended for prevention in the general population but will be tailored to treat individual cancer patients. The cost of production is estimated at 300,000 rubles per dose, but it will be provided free to Russian citizens. It remains unclear which specific types of cancer the vaccine is designed to treat.
View original story
Similar markets
More than 10 countries • 25%
None • 25%
1 to 5 countries • 25%
6 to 10 countries • 25%
Successful with expected results • 25%
Partially successful • 25%
Unsuccessful • 25%
Results inconclusive • 25%
Less than 10,000 doses • 25%
10,000 to 50,000 doses • 25%
50,001 to 100,000 doses • 25%
More than 100,000 doses • 25%
Less than 60% • 25%
60% to 70% • 25%
70% to 80% • 25%
More than 80% • 25%
Less than 100 • 25%
100 - 500 • 25%
500 - 1000 • 25%
More than 1000 • 25%
Less than 25% • 25%
25% to 50% • 25%
50% to 75% • 25%
More than 75% • 25%
Less than 500 • 25%
500-1000 • 25%
1001-2000 • 25%
More than 2000 • 25%
Less than 50% • 25%
50% to 74% • 25%
75% to 80% • 25%
More than 80% • 25%
Less than 50% • 25%
50% - 60% • 25%
60% - 70% • 25%
More than 70% • 25%
Less than 50% • 25%
50% to 75% • 25%
76% to 99% • 25%
100% or more • 25%